MedPath

Epithelium-On Corneal Cross-linking in Subjects 8 to 45 Years of Age With Keratoconus

Phase 3
Active, not recruiting
Conditions
Keratoconus
Registration Number
NCT06100939
Lead Sponsor
Epion Therapeutics
Brief Summary

A Multicenter, Randomized, Double-Masked, Sham-Controlled, Parallel-Group Phase 3 Study to Evaluate the Efficacy and Safety of Epithelium-On Corneal Cross-linking in Subjects 8 to 45 Years of Age With Keratoconus

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
400
Inclusion Criteria
  • Diagnosis of keratoconus
Exclusion Criteria
  • Minimal corneal thickness < 350 microns
  • Non-keratoconic ectatic disease
  • Contraindications or hypersensitivities to any required study medications
  • Pregnancy or breastfeeding
  • Certain concomitant ocular conditions

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Best Spectacle-Corrected Distance Visual Acuity (BSCDVA)Baseline to 12 months

BSCDVA will be assessed using Early Treatment Diabetic Retinopathy Study (ETDRS) visual acuity testing charts. The score ranges from 0 to 100, with a higher score representing better visual functioning.

Secondary Outcome Measures
NameTimeMethod
Vision-related Quality of Life as Assessed by the National Eye Institute 25-Item Visual Function Questionnaire (NEI-VFQ-25)Baseline to 12 months

The score on the NEI-VFQ-25 ranges from 0 to 100, with a higher score indicating greater functioning.

Trial Locations

Locations (13)

Nvision Eye Centers Rowland Heights

🇺🇸

Rowland Heights, California, United States

Goodman Eye Center

🇺🇸

San Francisco, California, United States

Center for Excellence in Eye Care

🇺🇸

Miami, Florida, United States

Chicago Cornea Consultants

🇺🇸

Hoffman Estates, Illinois, United States

Boston Vision

🇺🇸

Brookline, Massachusetts, United States

Ophthalmology Associates

🇺🇸

Saint Louis, Missouri, United States

The Eye Doctors at CNY Eye Care

🇺🇸

East Syracuse, New York, United States

Cincinnati Eye Institute

🇺🇸

Cincinnati, Ohio, United States

Devers Eye Institute

🇺🇸

Portland, Oregon, United States

Wills Eye Hospital

🇺🇸

Philadelphia, Pennsylvania, United States

Scroll for more (3 remaining)
Nvision Eye Centers Rowland Heights
🇺🇸Rowland Heights, California, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.